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Abstract 
researches demonstrate emotion disturbances in schizophrenia and schizophrenia spectrum disorders including deficits in 
emotional expression and recognition. Schizophrenia and schizophrenia spectrum disorders is typically regarded as a 
neurocognitive disorder, which suggests that emotional disturbances reflect abnormalities in brain areas important for emotion 
processing. The aim of this research was to investigate factor structure of alexithymia in patients with schizophrenia spectrum 
disorders. The research sample consisted of 180 patients with schizophrenia spectrum disorders from inpatients and outpatients of 
Mostafa Khomeini and Hazrat Rasoul hospitals. Toronto Alexithymia Scale (TAS-20) was used for collecting of data. 
Confirmatory factor analysis and structural equation model confirmed that alexuthymia has three different components in patients 
with schizophrenia spectrum disorders. The results suggest that this instrument has acceptable construct validity in the diagnosis 
and clinical research for patients with schizophrenia spectrum disorders. 
Keywords: alexithymia; emotions;  psychoses. 
1. Introduction  
Sifneos (1973) coined the word ‘‘alexithymia’’ derived from the Greek language: a = lack, lexis = word, thymos 
= emotions) which literally means ‘‘having no words for emotions’’. Alexithymia is not a diagnosis, but a construct 
useful for characterizing individuals who seem not to understand the emotional feelings they experience, or lack the 
words to describe these feelings to others. Alexithymia is conceptualized as a personality trait that is normally 
distributed in the population and is associated with increased risk of psychopathology (Franz et al. 2008). 
Furthermore, the construct of alexithymia is now considered part of the broader field of emotion research (Taylor 
and Bagby 2004).  
psychosis is a defining feature of schizophrenia. The three major components of psychosis are formal thought 
disorder, delusions, and hallucinations. The vast majority of patients with schizophrenia have at least one psychotic 
symptom (although DSM-IV allows a diagnosis of schizophrenia in the absence of psychosis if negative symptoms 
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and grossly disorganized or catatonic behavior are prominent). Several questions pertaining to the psychosis of 
schizophrenia have not been fully answered (Breier and Berg, 1999). 
The reduction of expression of emotion as found in alexithymia almost certainly implies a lack of, or 
dysregulation of, emotions (Bagby and Taylor, 1997). Likewise, the impairments in emotion-processing and 
emotion-regulating capacities underlying alexithymia may be a possible risk factor for a variety of both medical and 
psychiatric disorders, such as somatization and possibly schizophrenia (Taylor, Bagby and Parker, 1997). Previous 
studies that investigated alexithymia in schizophrenia demonstrated that patients with schizophrenia had more 
problems in identifying and communicating feelings (Stanghellini and Ricca, 1995;). These studies were limited, 
however, by the fact that no specific syndrome ratings, that is, positive or negative symptoms, were correlated with 
alexithymia scores. Furthermore, they did not evaluate verbal IQ to control for verbal abilities or sex differences.  
A great deal of theorizing and research has linked elevated levels of unpleasant emotions with cognitive– 
perceptual disturbances, ranging from odd perceptions and beliefs to delusions and hallucinations (e.g., Bentall et 
al., 2001; Freeman et al., 2001). Unpleasant emotion, however, represents only one of many aspects of emotional 
disturbances than may contribute to psychopathology (Berenbaum et al., 2003).  
The core problem in schizophrenia research is the lack of an adequate pathophysiological model. In spite of the 
large amount of studies (Bankier, Aigner and Bach, 2001) performed in many psychiatric populations, there is a 
relative lack of empirical data on alexithymia in schizophrenia. To our knowledge, alexithymia in schizophrenia has 
been explored from both a clinically-descriptive (Nkam, et al. 1997a, 1997b) and a phenomenologically oriented 
perspective (Stanghellini and Ricca, 1995). However, those studies suffer from an undue transposition of 
alexithymia construct in schizophrenic psychopathology. Haviland (Haviland and Reise, 1996) suggested, in fact, 
that the factorial structure of the alexithymia scales is different in the various psychiatric populations. Nkam et al 
(Nkam, et al. 1997) observed that negative schizophrenics had significantly higher total scores in alexithymia, and 
suggested that alexithymia is a trait characteristic in deficit patients, and a state related to many symptoms 
(flattening of affect, poverty of speech, depression and anxiety) in nondeficit ones ((Nkam, et al. 1997). 
Thus, in order to attempt an interpretation of the psychopathological meanings of alexithymia components, we 
performed a principal component analysis to define alexithymia factorial structure in our sample. Therefore, the 
main aim of this research is to investigate alexithymia in schizophrenia spectrum disorders  by Toronto Alexithymia 
Scale (TAS-20) , and present a model of alexithymia for these patients by this scale. 
2. Method 
2.1. Sample 
 
In This study, Between all outpatient and hospitalized patients with psychotic disorders (males and females) 
referred to psychiatric sections of Tehran city Hazrat Rasoul and Mostafa Khomeini hospitals, 180 patients with 
schizophrenia spectrum were selected as research sample. 
 
2.2. Procedure 
 
Investigators went to these hospitals, and studied cases of patients with schizophrenia spectrum disorders. 
Patients who had acute and severe disease status were excluded from subject lists and the other patients were used as 
only those who volunteered and were willing to answer questions. Questionnaire instruction were instructed to 
subjects and were asked to carefully read the questions and answers them according to their characteristics. 
descriptive statistics, confirmatory factor analysis and structural equation model were used for analyzing of data. 
 
2.3. Data collection instrument 
 
Toronto Alexithymia Scale-20 (TAS-20): Toronto Alexithymia Scale-20 (TAS-20) The TAS-20 (Bagby et al. 
1994a, 1994b) is a self-report scale comprised of 20 items. Each item is rated on a five point Likert scale ranging 
from 1 (strongly disagree) to 5 (strongly agree). The TAS-20 has been translated and validated in to 18 languages, 
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and its efficacy has been evaluated with confirmatory factor-analysis in 19 countries (Taylor et al. 2003). The TAS-
20 is a reliable and valid measure of emotion processing in adults which includes a total score and three subscales: 
Difficulty Identifying Feelings (DIF),Difficulty Describing Feelings (DDF), and Externally-Oriented Thinking 
(EOT). The first factor in the three-factor model for the TAS-20 consists of seven items assessing the ability to 
identify feelings and to distinguish them from the somatic sensations that accompany emotional arousal (e.g., ‘‘I am 
often confused about what emotion I am feeling’’ and ‘‘I have feelings that I can’t quite identify’’). Factor 2 consists 
of five items assessing the ability to describe feelings to other people (e.g., ‘‘I am able to describe my feelings 
easily’’ and ‘‘It is difficult for me to reveal my innermost feelings, even to close friends’’). Factor 3 consists of eight 
items assessing externally oriented thinking (e.g., ‘‘I prefer to analyze problems rather than just describe them’’ and 
‘‘Looking for hidden meanings in movies or plays distracts from their enjoyment’’). The empirically derived cut off 
score of 61 is used for identifying individuals with ‘‘high’’ or‘‘ low’’ alexithymia. This cut-off point was 
determined by three methods used in assessing the ‘‘goodness’’ of a diagnostic test—sensitivity, specificity, and 
predictive value in relation to a consensus decision by three clinicians who used interviews to designate individuals 
as ‘‘alexithymic’’ or‘‘non-alexithymic’’ (Taylor et al. 1988; Bagby et al.1994b;Taylor et al. 1997). Since then, a 
number of studies reported similar results with approximately 10% of the population exceeding the TAS-20 sum 
score threshold of 61 (Honkalampi et al. 2001; Franz et al. 2008). 
psychometric properties of Toronto Alexithymia Scale-20 (TAS-20) have been approved in past researches (eg., 
Pandley, Mandal, Taylor, Parker, 1996; Taylor, & Bagby, 2000).Ghorbani and et al. (2002) have studied 
psychometric properties of this scale in Iranian and American samples and have reported high reliability and validity 
for it. 
3. Findings 
Table 1 showing descriptive statistics of alexithymia variable and their components in both genders. In 
alexithymia variable, men have higher level of mean than women. Difficulty Identifying Feelings(DIF) is almost 
similar in men and women. Men have higher level of  Difficulty Describing Feelings (DDF) and Externally-
Oriented Thinking than women. 
 
Table 1: Descriptive statistics of alexithymia variable and their components in both genders 
 
Variable Gender Mean Std. Deviation Std. Error Mean 
alexithymia male 62.3125 12.07353 2.13432 female 58.3571 9.26249 1.75045 
DIF male 21.2500 6.55990 1.15964 female 21.3571 5.05682 .95565 
DDF male 16.3438 4.45486 .78752 female 14.4286 4.12246 .77907 
EOT male 24.7188 4.88734 .86397 female 22.8214 5.24266 .99077 
SEM showing that alexithymia (Toronto Alexithymia Scale-20) have  three different components and this structure is 
fit for patients with schizophrenia spectrum disorders. In this research, alexithymia construct  and Difficulty Identifying 
Feelings (DIF),Difficulty Describing Feelings (DDF), and Externally-Oriented Thinking (EOT) are latent variables. 
Alexithymia is Ksi (or exogenous variable) and DIF, DDF and EOT are Eta (or endogenous variable). DIF, DDF and 
EOT also are mediators between alexithymia and their indicators (a1 to a20 that are observable variables). a1, 
a3, a6, a7, a9, a13, and a14 are indicators of DIF; a2, a4, a11, a12, a17 are indicators of DDF and a5, a8, a10, 
a15, a16, a18, a19, a20 are indicators of EOT. 
In this research also, confirmatory factor analysis confirmed three structures of alexithymia in patients with 
schizophrenia spectrum disorders. 
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Chi Square = 137, df= 115, GFI= 0/93, AGFI= 0/87, RMSEA= 0/033 
Fig. 1. SEM showing model fit statistics and relationships between alexithymia and their components. *p < .05. 
4. Discussion and conclusion 
The aim of this research was to investigate factor structure of alexithymia in patients with schizophrenia 
spectrum disorders, for this purpose, we had used 180 patients with schizophrenia spectrum disorders to study 
alexithymia construct in these people. Toronto Alexithymia Scale (TAS-20) was used for collecting of data. 
Confirmatory factor analysis and Structural Equation Model (SEM) used for analyzing of data. Alexithymia is 
latent, Ksi and exogenous variable. Difficulty Identifying Feelings (DIF),Difficulty Describing Feelings (DDF), and 
Externally-Oriented Thinking (EOT) have mediators (endogenous variables) role between alexithymia and a1 to a20 
indicators (observable variable). a1, a3, a6, a7, a9, a13, and a14 are indicators of DIF; a2, a4, a11, a12, a17 are 
indicators of DDF and a5, a8, a10, a15, a16, a18, a19, a20 are indicators of EOT. In general, Fit indexes (Chi Square 
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= 137, df= 115, GFI= 0/93, AGFI= 0/87, RMSEA= 0/033) showed that the structure of alexithymia and the model 
used in this research conforms to reality.  
This result supports previous findings (Mueller et al., 2003; Cleland et al., 2005). According to Muller, et al 
(2003)  findings, three-factor model describes the structure of the TAS-20 in a meaningful way. First, a combination 
of the factors DIF and DDF can be justified because, following the authors of the TAS, ‘‘clearly, it is not possible to 
communicate feelings to others unless one is aware of and able to identify those feelings for oneself’’. This is 
confirmed by results of other studies (eg. Haviland  and Reise, 1996) with a combined factor DIF/DDF. Second, 
‘‘externally oriented thinking’’ may be characterized more precisely by the two factors ‘‘Pragmatic or concrete, 
nonanalytic thinking’’ and ‘‘Lack of appreciation or importance of emotions’’, a distinction ,which had already been 
previously reported by several authors.  
Also, Heshmati and et al. (2010) findings showed that alexithymia and their three different components has 
higher level in patients with schizophrenia spectrum disorders than normal people and patient with non-psychotic 
disorders. 
Being small sample size is limitation of this research. Therefore, we recommend to investigators to use large 
sample size in future investigation. It is also recommended that this instrument (Toronto Alexithymia Scale-20)  for 
other psychotic patients is also studied. 
generally, the results suggests that this instrument has acceptable construct validity in diagnosis and clinical researches for 
patients with schizophrenia spectrum disorders. 
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